House Republicans blocked a war‑powers resolution 213–214, leaving the administration free to continue operations in Iran while exposing tight margins in Congress. Lawmakers say the tally raises pressure for new briefings and votes.

Penn & Teller told the Supreme Court that a Texas death-row conviction was tainted by police 'investigative hypnosis' and filed a brief urging review.

A new JAMA Oncology analysis shows rising colorectal cancer deaths in adults 25–49 are concentrated among people without a four‑year degree, exposing widening prevention gaps.

A federal judge found developer Chris Donatelli forged his father’s signature on a $17M loan tied to Columbia Heights' Highland Park and ordered him to pay nearly $30M.

Google is reportedly negotiating a deal to let the Pentagon run Gemini in classified systems while proposing contract guardrails on surveillance and autonomous weapons.

A Navy reservist was arrested overseas after his wife was found dead inside a freezer at their Norfolk apartment on Feb. 5; authorities say extradition is expected.

Just Salad opened a Foggy Bottom location as it expands across D.C.; a fourth city store is reportedly on the way. Grand-opening promos and reusable-bowl perks are part of the rollout.

An August Starlink outage left unmanned Navy vessels offline for nearly an hour, exposing risks as the Pentagon leans more on SpaceX's satellites.

Allegations that Rep. Trevor Lee altered checks and tried to use his office to settle debts have prompted a legislative review and complicated his GOP primary fight.

EPA relaunched WRAP 2.0 to accelerate water reuse nationwide. North Texas wetlands and recycled‑water pipelines are being touted as early models.

After years of digging and detours, Arlington has unveiled Columbia Pike's multimodal overhaul. Utilities were buried and bus shelters upgraded, but some local merchants say the construction cost them dearly.

The SEC moved to let customers cross‑margin Treasuries with futures, aiming to reduce double‑margining and lower clearing costs while changing legal protections for opting‑in clients.

A federal appeals court revived Teva’s patent fight with Eli Lilly and sent the case back to Massachusetts, reopening a dispute that once produced a $176.5M jury award.